Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Irinotecan in Pancreas Cancer

In some situations, a healthcare provider may prescribe irinotecan (Camptosar®) to treat cancer of the pancreas. However, this is not an approved use of the drug. Irinotecan is approved to treat colon or rectal cancer that has spread to other areas of the body. Using irinotecan in the treatment of pancreatic cancer is considered an unapproved, or "off-label," use of the drug.
 
Irinotecan works is by blocking topoisomerase I, an enzyme that helps relax DNA that has been overwound (such as when DNA is duplicating so it can divide). This enzyme helps break the DNA strand to relieve the strain, and then helps put the strand back together. However, when irinotecan binds to topoisomerase I, it prevents the enzyme from repairing the broken DNA strand, which causes the cell to die.
 
(For more details, click What Is Irinotecan Used For?. This article presents an in-depth overview of this drug's uses, as well as information on who can use it.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.